Brazil Biotechnology Market Summary, Competitive Analysis and Forecast to 2028

Key Highlights

• The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
• The Brazilian biotechnology market recorded revenues of $17.5 billion in 2023, representing a negative compound annual growth rate (CAGR) of 0.6% between 2018 and 2023.
• The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $8.2 billion, equivalent to 47% of the market's overall value.
• Brazil, the second-largest producer of biotech crops globally, is experiencing a growing biotech startup ecosystem, with most biotech firms based in São Paulo, Minas Gerais, and Rio de Janeiro. Innovation in the biotech industry is driving growth, with the potential for significant therapeutic developments and advanced techniques like gene editing, gene therapy, and protein degradation.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Brazil
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Brazil
• Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Brazil biotechnology market with five year forecasts by both value and volume

Reasons to Buy

• What was the size of the Brazil biotechnology market by value in 2023?
• What will be the size of the Brazil biotechnology market in 2028?
• What factors are affecting the strength of competition in the Brazil biotechnology market?
• How has the market performed over the last five years?
• Who are the top competitors in Brazil's biotechnology market?